Remove 2020 Remove Networking Remove Safety
article thumbnail

The Rise of Audio Social Networks – Where Pharma Can Make an Impact

Pharma Marketing Network

Introducing new networks and features. In the summer of 2020, to stay-in-touch during the pandemic, a new audio-based, invite-only social media app, called Clubhouse , was launched that gathers people into audio chat rooms to discuss any topic imaginable. Today, the audio-only social network has over 6 million users.

article thumbnail

3 Insights From Re:Imagine Pharma Marketing 2020

Pharma Marketing Network

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. Pharma Marketing 2020: The Enduring Impact .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dr. Rod MacKenzie, 2020-2021 HBA Honorable Mentor

Pharma Marketing Network

HBA Honorable Mentor 2020-21, Dr. Rod MacKenzie. Head of the Discovery Technology Center in Cambridge, Massachusetts, Head of Discovery Research in Ann Arbor, Michigan, and Head of Drug Safety R&D. The post Dr. Rod MacKenzie, 2020-2021 HBA Honorable Mentor appeared first on Pharma Marketing Network.

article thumbnail

5 Trends That Will Shape Pharma Marketing in 2021

Pharma Marketing Network

Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Throughout 2020, the use of telehealth and remote monitoring has also drastically increased and may continue to be popular tools used between patients and HCPs in the year 2021.

article thumbnail

Navigating the Regulatory Environment of Pharmaceutical Marketing: Balancing Patient Safety and Industry Innovation

Pharma Marketing Network

In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation. In conclusion, navigating the regulatory environment of pharmaceutical marketing requires a delicate balance between patient safety and industry innovation.

Safety 52
article thumbnail

Eli Lilly reveals plans for new high-tech parenteral manufacturing site

European Pharmaceutical Review

Supporting European parenteral manufacture and supply Alongside expanding the company’s global parenteral product and device manufacturing network, the new facility will support the higher demand for Eli Lilly’s medicines, including its diabetes and obesity portfolio. This includes automation and high-speed manufacturing lines.

article thumbnail

Allotrope Medical announces FDA Safer Technologies Program (STeP) designation for their surgical device StimSit

Legacy MEDSearch

a company committed to advancing surgical efficiency and safety, announced that they have received Safer Technologies Program (STeP) designation from the FDA for their surgical device StimSite. “Surgeons are constantly learning new techniques, either robotics or laparoscopic, and safety is always front and center.

Medical 95